SCM
AQST icon

Sio Capital Management’s Aquestive Therapeutics AQST Stock Holding History

Sio Capital Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.18M Sell
1,486,175
-436,712
-23% -$1.84M 1.02% 32
2026
Q1 		$7.98M Buy
1,922,887
+929,792
+94% +$3.77M 1.14% 33
2025
Q4 		$6.42M Sell
993,095
-505,000
-34% -$3.15M 1.01% 26
2025
Q3 		$8.37M Buy
1,498,095
+550,606
+58% +$2.38M 2.12% 15
2025
Q2 		$3.14M Buy
947,489
+555,860
+142% +$1.59M 1.2% 23
2025
Q1 		$1.14M Buy
+391,629
New +$1.19M 0.34% 39

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Sio Capital Management's AQST Position: Q2 2026 in Review

Sio Capital Management reduced its Aquestive Therapeutics (AQST) stake by 23% in Q2 2026, selling an estimated $1.84M and leaving 1,486,175 shares worth $6.18M. The position accounts for 1.02% of the portfolio, ranked #32.

Sio Capital Management first reported a position in AQST in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.37M in Q3 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Sio Capital Management held 1,486,175 shares of Aquestive Therapeutics worth $6.18M as of Q2 2026.
  • Sio Capital Management sold 436,712 Aquestive Therapeutics shares in Q2 2026, an estimated $1.84M.
  • Aquestive Therapeutics made up 1.02% of Sio Capital Management's portfolio in Q2 2026, its #32 holding.
  • Sio Capital Management first reported a position in Aquestive Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Sio Capital Management's Aquestive Therapeutics position peaked at $8.37M in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.